ArticleViewAbstractPharmacognosy Journal,2023,15,6,1166-1176.DOI:10.5530/pj.2023.15.212Published:December 2023Type:Research ArticleImmunomodulatory and Antiallergic Potentials of the Bioactive Compounds of GingerB. Lalruatfela, P. B. Lalthanpuii, C. Lalrinmawia, and K. Lalchhandama B. Lalruatfela1 , P. B. Lalthanpuii2 , C. Lalrinmawia2 , K. Lalchhandama1,2* 1Department of Zoology, Pachhunga University College, Mizoram University, Aizawl 796001, INDIA. 2DBT-BUILDER National Laboratory, Pachhunga University College, Mizoram University, Aizawl 796001, INDIA. Abstract:Background: Allergy is an ever-increasing immune disorder and is often fatal under certain circumstances. Lack of total curative medication prompts the search for various compounds as the lead molecules. Ginger, Zingiber officinale Roscoe, is a well-established medicinal plant in different traditional practices. Its use as antiallergic or anti-inflammatory agent has been vindicated but the underlying mechanism of action is yet unknown. Method: In this study, we analyzed the phytocompounds characterized from ginger for their binding affinities on cysteinyl leukotriene receptor 1 (CysLTR1) and histamine H1 receptor (H1R) by molecular docking. The molecular interactions were compared against known agonists and antagonists of the two receptors. Results: The data indicate that ginger compounds have high binding affinity for both LTR1 and H1R comparable to those of antiallergic medications. The highest binding affinities were recorded for gingerenone-A (-7.3 kcal/mol) and zingiberol (-7.2 kcal/mol) on LTR1; and gingerenone-A (-8.7 kcal/mol) and α-curcumene (-8.0 kcal/mol) on H1R. Conclusion: In addition to antiallergic activity, molecular predications on the probable biological activities of the ginger compounds show that they can have a variety of medicinal applications including immunomodulatory and anticancer activities. Keywords:Allergy, Ginger, Histamine Receptor; Leukotriene Receptor, Molecular ModellingView:PDF (2.28 MB) PDF Images 3D model of the molecular binding site on cysteinyl leukotriene receptor 1 (CysLTR1) for antiallergic agents. A) Leukotriene D4 (LTD4) (brown) and montelukast (blue) share the same site. B) Binding of 6-dehydrogingerdione (purple). C) Binding of gingerenone-A (purple). D) Binding of gingerol (purple). E) Binding of paradol (purple). (purple). F) Binding of quercetin (purple). G) Binding of zingerone (purple). H) Binding of zingiberol (purple). I) Binding of α-farnesene (purple). J) Binding of zingiberene (purple). K) Binding of α-curcumene (purple). L) Binding of β-bisabolene (purple). M) Binding of β-sesquiphellandrene (purple). ‹ Elucidating the Use of the Plant Paeonia Anomala from the Ancient Medical Books Kept in Mongolia up Ethanolic Extract of Propolis from Tetragonula laeviceps: Selective Cytotoxicity for MCF-7 Breast Cancer cells ›